emerging glp-1 gip obesity treatments 2025 Dozens of new drugs are coming: these are the ones to watch Semaglutide and #tirzepatide effectively target
Description
Driving lasting outcomes.As demand for GLP-1 medications for weight loss soars, payers need innovative strategies to manage rising costs and drive lasting outcomes
We see the same thing with the association between GLP-1 receptor agonists and macular degeneration, a much more common form of blindness in which people (usually older adults) lose sight at the centre of their vision but can still see around it
Learn what it is, when the quiet comes, and how to track it day by day.
Nilesh Mehta at Digestive Disease Care
Kristin Louden, an Obesity Medicine nurse practitioner at Cleveland Clinic, discusses the truth and myths of GLP-1 weight loss medications.
